IVI granted 2 US patents on dysentery vaccine inventions
Patents will accelerate IVI's development of a vaccine against a deadly diarrheal disease that strikes millions in the developing world
29-Feb-2012 -
The International Vaccine Institute (IVI), an international organization based in Seoul devoted to research on the development and introduction of vaccines for the developing world, reached a milestone in its aim to prevent and control dysentery (also commonly called shigellosis or bloody ...
patents
Shigella bacteria
shigellosis